Drug name - Xtoro
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9119859 | MERLION PHARMS GMBH | Methods for treating otic infections |
Jul, 2030
(7 years from now) | |
| US8536167 | MERLION PHARMS GMBH | Methods for treating ophthalmic, otic, or nasal infections |
Aug, 2031
(8 years from now) | |
| US9504691 | MERLION PHARMS GMBH | Finafloxacin suspension compositions |
Nov, 2033
(11 years from now) | |
Drugs and Companies using FINAFLOXACIN ingredient
Treatment: Treatment of acute otitis externa
Dosage: SUSPENSION/DROPS;OTIC
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.3% | SUSPENSION/DROPS;OTIC | Discontinued |
availability in other generic markets.
Click on the highlighted region to filter.